20-F/A: C21 Investments Inc. Files Transition Report Following Fiscal Year-End Change

C21 Investments Inc. files a transition report on Form 20-F/A to reflect its change in fiscal year-end from January 31 to March 31.

Summary

• C21 Investments Inc. filed a transition report on Form 20-F/A due to a change in its fiscal year-end from January 31 to March 31.
• The company's next fiscal year-end will be March 31, 2025.
• The transition report includes financial results for the two-month period ended March 31, 2024.
• Revenue for the two months ended March 31, 2024, was $4.5 million.
• The company completed the acquisition of a retail cannabis store from Deep Roots Harvest Inc. for $3.5 million on June 7, 2024.
• The new Reno dispensary rebranded 'Silver State' opened on June 26, 2024.
• On May 6, 2024, the Company closed a private placement of C$4 million from the issuance of convertible debentures units.
• The company is involved in ongoing litigation, including the Oregon Action and the British Columbia Action.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While there are positive developments like the acquisition of a new dispensary and a private placement, there are also concerns about declining revenue, ongoing litigation, and regulatory risks. The sentiment is neutral, reflecting both opportunities and challenges for the company.

Positives

• The company completed the acquisition of a retail cannabis store from Deep Roots Harvest Inc. for $3.5 million on June 7, 2024.
• The new Reno dispensary rebranded 'Silver State' opened on June 26, 2024.
• On May 6, 2024, the Company closed a private placement of C$4 million from the issuance of convertible debentures units.
• The company's Nevada cultivation expansion was completed in January 2023, doubling the company's annual production capacity to 8,100 pounds of high-quality flower.

Negatives

• The company's revenue for the two months ended March 31, 2024, was $4.5 million, a decrease compared to previous periods.
• The company is involved in ongoing litigation, including the Oregon Action and the British Columbia Action.
• The company has a working capital deficit of $6,908,835 as of March 31, 2024.
• The company's internal controls over financial reporting were not effective as of the Evaluation Date.

Risks

• Cannabis remains illegal under U.S. federal law, which may subject the company to regulatory or legal enforcement.
• The company may have difficulty accessing the services of banks and processing credit card payments.
• The company's operations in the United States may be subject to heightened scrutiny.
• Unfavorable publicity or consumer perception of cannabis may have an adverse effect on the demand for the company's products.
• The business premises of the company are a target for theft.
• The company may face increased competition in the marketplace for cannabis.
• The company may not have adequate insurance coverage.
• The company faces risks related to tax credits and deductions due to Section 280E of the U.S. Internal Revenue Code.
• The company is dependent on governmental approvals, licenses and permits to operate, and failure to obtain or maintain such approvals, licenses and permits may adversely affect the Company's operations.
• The Company has identified material weaknesses in our internal control over financial reporting, and if we are unable to achieve and maintain effective internal control over financial reporting or effective disclosure controls, we may be at risk to accurately report financial results or detect fraud, which could have a material adverse effect on our business.

Future Outlook

The Company's strategic initiatives over the next 12 months include extending its Nevada retail footprint and continuing its disciplined approach to growth and financing.

Management Comments

• President and CEO of C21, Sonny Newman commented: 'With the dispensary's desirable location in a high traffic, flourishing area of South Reno, we anticipate strong revenue growth from this acquisition, along with the added benefit of allowing us to expand the portion of our cultivation capacity sold through our retail channel.'

Industry Context

The report acknowledges the evolving regulatory landscape and increasing competition in the cannabis industry, particularly the growing presence of multi-state operators in Nevada.

Comparison to Industry Standards

• The 2% decline in revenues in the year ended January 31, 2024 compared to the year ended January 31, 2023 is consistent with industry trends since the easing of pandemic restrictions.
• According to Headset, a cannabis industry market analysis site, Nevada cannabis sales have dropped by 6% over the same 12 months ending January 31, 2024.

Management Changes

Legal Proceedings

• The company is involved in ongoing litigation, including the Oregon Action and the British Columbia Action.
• On April 2, 2024, the Court entered a limited judgment of dismissal confirming dismissal of the Company and the other defendants who were no longer named in the case.
• On April 6, 2024, the Company filed a motion to recover costs and attorney fees and the other defendants who were no longer named in the case, in the amount of $107,622.50 in attorney's fees, and $1,252 in costs.
• Additionally, a settlement conference is set for October 22, 2024, and a twelve-person jury trial is scheduled for November 19, 2024.

Related Party Transactions

• During the two months ended March 31, 2024, the Company made payments totaling $nil to Sonny Newman, the President and Chief Executive Officer of the Company in connection with the Newman Note.
• On February 13, 2023, and various subsequent dates in February and March 2023, C21 entered into the Cancellation Agreements in connection with the Swell Earn-Out share entitlements with a majority of the Swell Vendors.
• C21 agreed to collectively pay cash in the amount of $575,136 in exchange for their entitlement to redeem 4,792,800 Swell Earn-Out Shares.
• On September 1, 2019, the Company entered into a Consulting Services Agreement with CB1 Capital Management, a company in which Todd Harrison is a principal.
• Effective February 1, 2022, the monthly consulting fee was changed to $10,000 and the agreement terminates on March 31, 2023.
• Effective April 1, 2023, the monthly consulting fee was changed to $7,500 and effective October 1, 2023, the monthly consulting fee changed to $5,000.
• The agreement terminates on September 30, 2024.

Stakeholder Impact

• Shareholders may experience dilution from future financings.
• The Company's indebtedness could have a number of adverse impacts on the Company, including reducing the availability of cash flows to fund working capital and capital expenses.
• There is a limited market for resale of the Company's common shares.
• The price of the Common Shares has been and may continue to be volatile.
• Maintaining a public listing is costly and will add to the Company's legal and financial compliance costs.
• The Company has not paid dividends and does not anticipate paying dividends for the foreseeable future.

Next Steps

• The Company will continue to integrate and rebrand the South Reno dispensary under the Silver State Relief banner.
• The Company will continue to monitor U.S. federal law and the law in all jurisdictions where it is active, with respect to (a) compliance with applicable state regulatory frameworks, and (b) potential exposure and implications arising from U.S. federal law.

Key Dates

Keywords

cannabis, Nevada, cultivation, dispensary, retail, legalization, financials, C21 Investments, regulation